These educational materials were made in collaboration with and approved by the MS Department of Health & The National Center for Cannabis Research and Education. Designed to help patients, practitioners and industry operators understand the fundamentals of medical cannabis use and the rules & regulations specific to Mississippi’s Medical Cannabis Program, these materials are free to share and download.
For Patients
-
- July 1, 2025 Telemedicine Changes
-
- Forms of Cannabis & Their Uses
-
- 2nd Amendment Rights and & Medical Cannabis
-
- Traveling with Medical Cannabis in MS
-
- MMCP Caregiver Guide
-
- MMCP Patient Application Guide
-
- What is a Unit?
-
- Know Your Rights as a Medical Cannabis Patient
-
- Benefits & Risks of Medical Cannabis
For Practitioners
-
- Cannabis Hyperemesis Syndrome
-
- Pregnancy & Cannabis
-
- Chronic Pain & Cannabis
-
- July 1, 2025 Telemedicine Changes
For Industry Operators
-
- MMCP Work Permit Application Guide
-
- MMCP Tax Compliance Guide
-
- Verifying a Medical Cannabis Card
-
- MMCP Licensing/Transparency Portal Guide
-
- MMCP Marketing & Advertising Restrictions
-
- MMCP Packaging & Labeling Guide
SOURCES AND REFERENCE MATERIALS
Main Source – Cannabis Policy Impacts Public Health and Health Equity
Community Toolkit Sources
Cannabis and Pregnancy
Early Maternal Prenatal Cannabis Use and Child Developmental Delays (JAMA)
Associations Between Prenatal Cannabis Use and Maternal Health Outcomes (JAMA)
Prenatal Cannabis Use and Maternal Pregnancy Outcomes (JAMA) (ORIGINAL STUDY)
Cannabis Exposure and Adverse Pregnancy Outcomes Related to Placental Function (JAMA)
Prenatal cannabis exposure, the brain, and psychopathology during early adolescence (NMH)
Cannabis and Pregnancy – CDC
Cannabis and Pregnancy – American College of Obstetricians and Gynecologists
HEALthy Brain and Child Development (HBCD) Study (NIH)
Risks vs. Benefits
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies (BMJ)
Cannabis Frequently Asked Questions (CDC) – (Cannabis Use Disorder + Risks/Benefits)
Brain Function Outcomes of Recent and Lifetime Cannabis Use (JAMA)
Clarification of Insufficient Evidence
The medicinal benefits of cannabis are mostly unknown (NASEM)
The relationship between cannabis use and schizophrenia is complex (NASEM)
Vulnerable Populations
Adolescents
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence (NIH)
Cannabis Use During Adolescence and Young Adulthood and Academic Achievement: A Systematic Review and Meta-Analysis (JAMA)
The Developmental Trajectory to Cannabis Use Disorder (American Journal of Psychiatry)
A systematic evidence map of the association between cannabis use and psychosis-related outcomes across the psychosis continuum: An umbrella review of systematic reviews and meta-analyses (Psychiatry Research – Volume 331)
Cannabis and anxiety and depression in young adults: a large prospective study (NIH)
Pre-Existing Mental Health Conditions
Cannabis Use and Symptomatic Relapse in First Episode Schizophrenia: Trigger or Consequence? Data From the OPTIMISE Study (Oxford Academic)
Age-dependent association of cannabis use with risk of psychotic disorder
What to know about cannabis and bipolar disorder (Medical News Today)
- Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research
- Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership